Gene therapy revolutionizes retinal disease treatment, offering long-lasting solutions and reducing the need for frequent injections in patients with nAMD.
Modern Retina November and December 2025
nAMD treatment options may offer positive outcomes to patients by reducing fluid fluctuations associated with poorer outcomes.
Ophthalmology advances with AI diagnostics and pediatric trauma insights, merging technology and compassion to enhance patient care and outcomes.
Advertisement
Advertisement
Trending on Modern Retina
1
The gene therapy shift: A closer look at the science powering next-generation retinal treatments
2
Understanding fluid fluctuation in retinal disorders
3
Inflammasome Therapeutics completes phase 2 trial enrollment for K8 in GA
4
Evaluating Progressive Multifocal Geographic Atrophy in an Asymptomatic 81-Year-Old Male
5
